Stomach cancer serological detection and identification kit and method
A technology of serology and kits, which is applied in gastric cancer serology detection and identification kits and fields, can solve the problems of high false positive rate, patient mental stress and property loss, low detection sensitivity and specificity, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0049] Experimental example 1 Screening of exosomal miRNAs highly correlated with gastric cancer
[0050] 1. Serum exosome isolation and RNA extraction
[0051] 1) Take 2ml of fresh blood tested positive for gastric cancer by routine blood testing and put it into a vacuum blood collection tube-separating gel / coagulant tube (purchased from Greiner Bio-One Company), and let stand at room temperature for 15 minutes.
[0052] 2) Thermo ST16R refrigerated centrifuge at 1000×g, centrifuge at 4°C for 10 minutes.
[0053] 3) Carefully transfer the serum to a 15ml centrifuge tube and centrifuge at 2000×g for 30 minutes. Transfer the supernatant to a new 15ml centrifuge tube.
[0054] 4) Centrifuge at 10,000×g in a Thermo ST16R refrigerated centrifuge at 4°C for 40 minutes. The supernatant was transferred to a new ultracentrifuge tube (Beckman Company, Cat No. / ID: 355654). Beckman Optima L-100XP Ultracentrifuge Ultracentrifuge at 100,000×g, 4°C for 70 minutes.
[0055] 5) Discard t...
experiment example 2
[0079] Experimental example 2 Preparation and use of gastric cancer serum detection and identification kit
[0080] 1. Kit
[0081] The kit provided in this example consists of cel-miR-39-5p fragment, primers, vacuum blood collection tube-separation gel / coagulant tube and vacuum blood collection needle assembly, exosome isolation kit, and exosome miRNA extraction It consists of kits, reverse transcription reagents and real-time fluorescent quantitative PCR reagents.
[0082] Primers (see Table 1, Table 2) are as follows: cel-miR-39-5p, hsa-miR-375, hsa-miR-590-5p, hsa-miR-19b-3p, hsa-miR-100-5p and hsa - miR-16.
[0083] hsa-miR-122-3p, hsa-miR-122-5p, hsa-miR-125a-3p, hsa-miR-125a-5p, hsa-miR-193b-5p, hsa-miR-205-5p, hsa- miR-214-3p, hsa-miR-1307-3p, hsa-miR-19a-3p, hsa-miR-21-3p, hsa-miR-215-5p, hsa-miR-33a-5p, hsa-miR- 494-3p, hsa-miR-501-3p and hsa-miR-598-3p. Primers for real-time quantitative PCR were synthesized by Shanghai Shenggong Company or Suzhou Jinweizhi Bio...
experiment example 3
[0151] Experimental Example 3 Preparation and use of gastric cancer serum detection and identification kit
[0152] Table 7 clinical serological test results:
[0153]
[0154] Steps (1)-(4) are the same as in Example 2.
[0155] (5) Analysis of fluorescence quantitative detection results
[0156] Taking the expression level of cel-miR-39-5p as a reference, when calculating the expression level of miRNA, use ΔCt=Ct(miRNA)-Ct(cel-miR-39-5p), ΔΔCt=ΔCt(patient)-ΔCt(normal individual ), the relative expression of miRNA is 2-ΔΔCt.
[0157] For patients whose serum test results of gastric cancer CA19-9, CA24-2 and CEA are positive or all negative, by analyzing the expression of miRNA in the serum exosomes of the patients and the normal human serum exosomes , and the judging criteria of 20 miRNAs combinations can also be used.
[0158] Table 8: 20 miRNA qPCR results, C T value
[0159]
[0160] Table 9: Result of relative expression of 20 miRNAs
[0161]
[0162]
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com